Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Master's Award: Canada Graduate Scholarships

Université de Montréal

$17,500.00

Genetic Models of Amyotrophic Lateral Sclerosis (ALS) in Zebrafish.

FY 2009-10

Summary
Amyotrophic Lateral Sclerosis (ALS), or Lou Gherig's disease is a neurodegenerative disorder, affecting more than 1 adult in 100,000 with a lifetime risk as high as 1:1000. It is the third most common neurological disorder. The onset of this disease is around 50 years of age, and results in the deterioration of the motor neurons and of the muscles they innervate, leading to a progressive paralysis and eventually death, within 2 to 5 years after the onset. Currently, there is no effective treatment for this disease. I will characterize a line of zebrafish that is stably expressing a mutation in the human gene (TARDBP) that is known to have a role in the development of ALS. Using this line and the knowledge it will provide us about the disease mechanisms, I will test a large number of small molecules already approved for clinical use to see if they have any effect on the behaviour of the diseased fish. My aim is to rescue the fish expressing the mutant gene. If this is the case, further studies will be done to test the efficacy of the drug in several models. We hope this screen will lead to clinical tests and eventually therapeutic uses to treat ALS patients.
Program
Master's Award: Canada Graduate Scholarships
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
201320
Name
Lissouba Tatarinoff Alexandra
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Neurosciences, Mental Health and Addiction
Theme2
Biomedical
Prcname2
Canada Graduate Scholarships Master's Awards A
Projecttitle
Genetic Models of Amyotrophic Lateral Sclerosis (ALS) in Zebrafish.
Programtype2
Studentship Programs
Orgnameinp2
Université de Montréal
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Als; Central Nervous System; High-Throughput Screening; Motor Neuron; Neurodegenerative Diseases; Neuromuscular Diseases; Tdp-43; Zebrafish
Abstract
Amyotrophic Lateral Sclerosis (ALS), or Lou Gherig's disease is a neurodegenerative disorder, affecting more than 1 adult in 100,000 with a lifetime risk as high as 1:1000. It is the third most common neurological disorder. The onset of this disease is around 50 years of age, and results in the deterioration of the motor neurons and of the muscles they innervate, leading to a progressive paralysis and eventually death, within 2 to 5 years after the onset. Currently, there is no effective treatment for this disease. I will characterize a line of zebrafish that is stably expressing a mutation in the human gene (TARDBP) that is known to have a role in the development of ALS. Using this line and the knowledge it will provide us about the disease mechanisms, I will test a large number of small molecules already approved for clinical use to see if they have any effect on the behaviour of the diseased fish. My aim is to rescue the fish expressing the mutant gene. If this is the case, further studies will be done to test the efficacy of the drug in several models. We hope this screen will lead to clinical tests and eventually therapeutic uses to treat ALS patients.
Competitiondate
201002
Approvedterm2
1 yr 0 mth
Pinamesdelim
Lissouba Tatarinoff, Alexandra
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~